Shareholders OK Nichi-Iko’s Delisting, Turnaround under New Management; President to Exit March 8

Nichi-Iko Shareholders Walking into Tamura Building in Toyama Shareholders of debt-heavy Nichi-Iko Pharmaceutical on February 17 approved all 10 proposals related to the company’s turnaround plan under a new management scheme, including its stock delisting. President Yuichi Tamura revealed that...read more